Insider · CIK 0001495318
Theron I Gilliam
director
Files at LEN (LENNAR CORP /NEW/), GMS (GMS Inc.). First filing Apr 2, 2025, latest Apr 2, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $916k sold
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | LEN LENNAR CORP /NEW/ | AGrant or award Class A Common Stock | +15 | $76.13 | $1,142 | 36,838 | 4 d ago |
| Sep 4, 2025 | GMS GMS Inc. | UTender of shares Common Stock | -28,063 | $110.00 | $3.1M | 4,794 | Sep 8, 2025 |
| Sep 4, 2025 | GMS GMS Inc. | DDisposition to issuer Common Stock | -4,794 | $110.00 | $527k | 0 | Sep 8, 2025 |
| Sep 4, 2025 | GMS GMS Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -1,141 | $0.00 | $0 | 0 | Sep 8, 2025 |
| Aug 1, 2025 | GMS GMS Inc. | MOption exercise Common Stock | +1,350 | $0.00 | $0 | 32,857 | Aug 5, 2025 |
| Aug 1, 2025 | GMS GMS Inc. | MOption exercise Restricted Stock Unitsderivative | -1,350 | $0.00 | $0 | 0 | Aug 5, 2025 |
| Aug 1, 2025 | GMS GMS Inc. | AGrant or award Restricted Stock Unitsderivative | +1,141 | $0.00 | $0 | 1,141 | Aug 5, 2025 |
| Apr 9, 2025 | LEN LENNAR CORP /NEW/ | AGrant or award Class A Common Stock | +1,242 | $0.00 | $0 | 34,484 | Apr 10, 2025 |
| Apr 1, 2025 | GMS GMS Inc. | MOption exercise Common Stock | +24,474 | $14.77 | $361k | 43,981 | Apr 2, 2025 |
| Apr 1, 2025 | GMS GMS Inc. | SOpen-market sale Common Stock | -12,474 | $73.46 | $916k | 31,507 | Apr 2, 2025 |
| Apr 1, 2025 | GMS GMS Inc. | MOption exercise Stock Option (Right to Buy)derivative | -24,474 | $14.77 | $361k | 0 | Apr 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.